This week on Contemporary OB/GYN®: Jan. 17 to Jan. 21
Here's what's coming to Contemporary OB/GYN® this week.
The need for a universal endometriosis classification
A literature search revealed there is no international agreement on how to characterize or classify endometriosis.
Read now
Treating recurrent vulvovaginal candidiasis with honey
Because the mechanism of action of medical-grade honey (MGH) is based on enhancing wound healing and exerting strong broad-spectrum antimicrobial activity, MGH may also help to treat recurrent vulvovaginal candidiasis (RVVC), according to a review in the Journal of Fungi.
Microbial interplay of recurrent vulvovaginal candidiasis pathobiology
A clinical study has confirmed that the pathophysiology of recurrent vulvovaginal candidiasis (RVVC) relies primarily on Candida albicans (C. albicans)-specific attributes like hyphal morphogenesis, biofilm formation and pathogenesis that differentiate it from other prominent non-albicans C. (NAC) species.
Patient perspectives on vulvovaginal candidiasis
Among women with vulvovaginal candidiasis (VVC) or recurrent VVC (RVVC), the three 3 most common signs and /symptoms are itching (91.2%), burning (68.3%), and redness (58.1%), according to an online patient survey in BMC Womens Health.
Increase in ED visits for hypertensive disorders from 2006 to 2020 reported
September 18th 2024In a recent study, reported rates on emergency department utilization for hypertensive disorders of pregnancy and the postpartum period were higher in 2020 than 2006, with rates especially high among non-Hispanic Black, Hispanic, and Asian patients.
Read More
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
